Concepedia
Statistics
Publications
14
Citations
2.5K
H-Index
Active since
2000
Affiliations
AstraZeneca (United States)(Current)
University of Washington
Pfizer (United States)
Weill Cornell Medicine
North Carolina Clinical Research
Samir Arora is an author at AstraZeneca (United States) specializing in pharmacotherapy, pharmacology, and pharmacy.
Publications per year
2000–2023
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
Louis J. Aronne, Naveed Sattar, Deborah B. Horn et al. · JAMA · 2023 · 709 citations · Full text
Agriculture, Pharmacotherapy, Clinical Pharmacology +16
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations
Medicine, Pharmacology, Pharmacotherapy +16
Major Factors Influencing Breastfeeding Rates: Mother's Perception of Father's Attitude and Milk Supply
Samir Arora, Cheryl McJunkin, Julie Wehrer et al. · PEDIATRICS · 2000 · 447 citations
Public Health, Family Medicine, Maternal Health +17
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 227 citations · Full text
Medicine, Cardiology, Pharmacology +14
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
Gary T. Ferguson, J. Mark FitzGerald, Eugene R. Bleecker et al. · The Lancet Respiratory Medicine · 2017 · 123 citations
Pharmacy, Pharmacology, Pharmacotherapy +7
1–5 of 14